32 related articles for article (PubMed ID: 16404785)
1. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
Li CI; Malone KE; Saltzman BS; Daling JR
Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
[TBL] [Abstract][Full Text] [Related]
2. StatBite: Breast cancer: 5-year survival rates in U.S. for selected histologic types by stage.
J Natl Cancer Inst; 2009 Oct; 101(19):1303. PubMed ID: 19755678
[No Abstract] [Full Text] [Related]
3. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
Hudis CA; Barlow WE; Costantino JP; Gray RJ; Pritchard KI; Chapman JA; Sparano JA; Hunsberger S; Enos RA; Gelber RD; Zujewski JA
J Clin Oncol; 2007 May; 25(15):2127-32. PubMed ID: 17513820
[TBL] [Abstract][Full Text] [Related]
4. Factors influencing survival in infiltrating lobular carcinoma of the breast.
Sariego J; Byrd M; Kerstein M; Matsumoto T
Am Surg; 1993 Jul; 59(7):405-9. PubMed ID: 8391768
[TBL] [Abstract][Full Text] [Related]
5. Early-stage breast cancer rates rise sharply as invasive breast cancer levels off.
Oncology (Williston Park); 2005 Aug; 19(9):1176. PubMed ID: 16404785
[No Abstract] [Full Text] [Related]
6. Current management of noninvasive (in situ) breast cancer.
Silverstein MJ
Adv Surg; 2000; 34():17-41. PubMed ID: 10997214
[No Abstract] [Full Text] [Related]
7. Breast cancer: non-metastatic.
Dixon JM; Gregory K; Johnston S; Rodger A
Clin Evid; 2002 Jun; (7):1603-30. PubMed ID: 12230775
[No Abstract] [Full Text] [Related]
8. Breast cancer: non-metastatic.
Dixon JM; Gregory K; Johnston S; Rodger A
Clin Evid; 2002 Dec; (8):1811-39. PubMed ID: 12603971
[No Abstract] [Full Text] [Related]
9. Biology of ductal carcinoma in situ classification based on biologic potential.
Tsikitis VL; Chung MA
Am J Clin Oncol; 2006 Jun; 29(3):305-10. PubMed ID: 16755185
[TBL] [Abstract][Full Text] [Related]
10. High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer.
Rennstam K; Hedenfalk I
Breast Cancer Res; 2006; 8(4):213. PubMed ID: 16895590
[TBL] [Abstract][Full Text] [Related]
11. Microinvasive carcinoma of the breast: a diagnosis in search of a definition.
Schnitt SJ
Adv Anat Pathol; 1998 Nov; 5(6):367-72. PubMed ID: 10095878
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
